Subtopic Deep Dive
Placental Site Trophoblastic Tumor
Research Guide
What is Placental Site Trophoblastic Tumor?
Placental site trophoblastic tumor (PSTT) is a rare gestational trophoblastic disease characterized by malignant proliferation of intermediate trophoblast cells producing human placental lactogen rather than human chorionic gonadotropin.
PSTT exhibits chemoresistance and aggressive local invasion, distinguishing it from other gestational trophoblastic neoplasms. Diagnosis relies on immunohistochemistry for human placental lactogen positivity (Seckl et al., 2010; 966 citations). Management emphasizes surgical resection, with limited chemotherapy response (Lurain, 2010; 778 citations). Over 50 papers address PSTT within gestational trophoblastic disease studies.
Why It Matters
PSTT requires hysterectomy in most cases, impacting fertility, prompting research into prognostic factors and fertility-sparing surgery (Seckl et al., 2010; Lurain, 2010). Multidisciplinary approaches improve survival from 40% to over 90% post-2000 due to refined staging and multi-agent chemotherapy for metastases (Ngan et al., 2018; 426 citations). Immunohistochemical markers like human placental lactogen guide differential diagnosis from choriocarcinoma, enabling targeted management (Seckl et al., 2013; 371 citations).
Key Research Challenges
Chemoresistance in PSTT
PSTT shows poor response to chemotherapy effective in other gestational trophoblastic diseases due to low hCG production. Surgery remains primary treatment, but metastatic cases challenge multi-agent regimens (Seckl et al., 2010). Prognostic models incorporating mitotic count and necrosis are needed (Lurain, 2010).
Immunohistochemical Diagnosis
Distinguishing PSTT from epithelioid trophoblastic tumor relies on human placental lactogen expression, but marker overlap complicates pathology. Molecular profiling aids but lacks standardization (Ngan et al., 2018). Validation across cohorts remains limited (Seckl et al., 2013).
Fertility Preservation Strategies
Hysterectomy standard for localized PSTT conflicts with reproductive-age patients' needs. Fertility-sparing surgery criteria based on stage and hCG levels require prospective validation (Lurain, 2010). Recurrence risks post-conservative management need long-term studies (Ngan et al., 2015; 359 citations).
Essential Papers
Gestational trophoblastic disease
Michael J. Seckl, Neil J. Sebire, Ross S. Berkowitz · 2010 · The Lancet · 966 citations
Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole
John R. Lurain · 2010 · American Journal of Obstetrics and Gynecology · 778 citations
The diagnosis, treatment, and follow-up of cesarean scar pregnancy
Ilan E. Timor‐Tritsch, Ana Monteagudo, Rosalba Santos et al. · 2012 · American Journal of Obstetrics and Gynecology · 434 citations
Update on the diagnosis and management of gestational trophoblastic disease
Hys Ngan, Michael J. Seckl, Ross S. Berkowitz et al. · 2018 · International Journal of Gynecology & Obstetrics · 426 citations
Abstract Gestational trophoblastic disease ( GTD ) arises from abnormal placenta and is composed of a spectrum of premalignant to malignant disorders. Changes in epidemiology of GTD have been noted...
Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Michael J. Seckl, Neil J. Sebire, Rosemary A. Fisher et al. · 2013 · Annals of Oncology · 371 citations
New discoveries on the biology and detection of human chorionic gonadotropin
Laurence A. Cole · 2009 · Reproductive Biology and Endocrinology · 285 citations
Diagnosis and Management of Ectopic Pregnancy
O' Herlihy, C; Centre For Maternal, Child Enquiries et al. · 2016 · BJOG An International Journal of Obstetrics & Gynaecology · 284 citations
What are the surgical, pharmacological or conservative treatment options for abdominal pregnancy?Laparoscopic removal is an option for treatment of early abdominal pregnancy.[New 2016] D Possible a...
Reading Guide
Foundational Papers
Start with Seckl et al. (2010; 966 citations) for GTD spectrum including PSTT overview, then Lurain (2010; 778 citations) for pathology and diagnosis details.
Recent Advances
Study Ngan et al. (2018; 426 citations) for updated epidemiology and management, and Seckl et al. (2013; 371 citations) for ESMO guidelines.
Core Methods
Core techniques include hPL immunohistochemistry, hCG/p-hCG assays (Cole, 2009), surgical staging, and multi-agent chemotherapy for metastases (Ngan et al., 2015).
How PapersFlow Helps You Research Placental Site Trophoblastic Tumor
Discover & Search
Research Agent uses searchPapers('Placental Site Trophoblastic Tumor chemoresistance') to retrieve Seckl et al. (2010; 966 citations), then citationGraph reveals citing works on management, and findSimilarPapers expands to PSTT immunohistochemistry studies. exaSearch queries 'PSTT human placental lactogen markers' for rare-case reports.
Analyze & Verify
Analysis Agent applies readPaperContent on Seckl et al. (2010) to extract hCG vs. hPL data, verifyResponse with CoVe cross-checks chemoresistance claims against Lurain (2010), and runPythonAnalysis plots survival rates from extracted cohorts using pandas. GRADE grading assesses evidence quality for ESMO guidelines (Seckl et al., 2013).
Synthesize & Write
Synthesis Agent detects gaps in fertility-sparing PSTT trials via contradiction flagging across Ngan et al. (2018) and Lurain (2010), then Writing Agent uses latexEditText for case review drafts, latexSyncCitations integrates Seckl references, and latexCompile generates formatted reports. exportMermaid visualizes PSTT diagnostic flowcharts.
Use Cases
"Extract survival data from PSTT cohorts and compute Kaplan-Meier curves"
Research Agent → searchPapers('PSTT prognosis') → Analysis Agent → readPaperContent(Seckl 2010) → runPythonAnalysis(pandas survival analysis, matplotlib plot) → researcher gets CSV-exported curves and statistics.
"Draft LaTeX review on PSTT management guidelines"
Synthesis Agent → gap detection(Ngan 2018, Lurain 2010) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 GTD papers) → latexCompile(PDF) → researcher gets compiled review with figures.
"Find code for hCG/hPL immunohistochemical analysis in trophoblastic tumors"
Research Agent → searchPapers('PSTT hPL quantification') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets Python scripts for marker intensity analysis.
Automated Workflows
Deep Research workflow scans 50+ GTD papers via searchPapers and citationGraph, synthesizing PSTT epidemiology report with GRADE-scored evidence from Seckl et al. (2010). DeepScan applies 7-step CoVe analysis to Ngan et al. (2018) guidelines, verifying chemoresistance claims. Theorizer generates hypotheses on hPL-targeted therapies from Lurain (2010) pathology data.
Frequently Asked Questions
What defines placental site trophoblastic tumor?
PSTT is a gestational trophoblastic neoplasm from intermediate trophoblasts producing human placental lactogen, with low hCG and chemoresistance (Seckl et al., 2010).
What are standard diagnostic methods for PSTT?
Diagnosis uses immunohistochemistry showing hPL positivity and low hCG, with histology distinguishing from choriocarcinoma (Lurain, 2010; Seckl et al., 2013).
Which papers establish PSTT management?
Seckl et al. (2010; 966 citations) and Ngan et al. (2018; 426 citations) outline surgical priority and ESMO guidelines (Seckl et al., 2013; 371 citations).
What open problems exist in PSTT research?
Fertility-sparing criteria need validation, molecular prognostic markers require standardization, and chemoresistance mechanisms lack targeted therapies (Ngan et al., 2015).
Research Gestational Trophoblastic Disease Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Placental Site Trophoblastic Tumor with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers